JPWO2022201644A1 - - Google Patents

Info

Publication number
JPWO2022201644A1
JPWO2022201644A1 JP2023508458A JP2023508458A JPWO2022201644A1 JP WO2022201644 A1 JPWO2022201644 A1 JP WO2022201644A1 JP 2023508458 A JP2023508458 A JP 2023508458A JP 2023508458 A JP2023508458 A JP 2023508458A JP WO2022201644 A1 JPWO2022201644 A1 JP WO2022201644A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023508458A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022201644A1 publication Critical patent/JPWO2022201644A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023508458A 2021-03-26 2021-12-03 Pending JPWO2022201644A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021052802 2021-03-26
PCT/JP2021/044426 WO2022201644A1 (ja) 2021-03-26 2021-12-03 Ｔｍｐｒｓｓ２発現抑制用医薬組成物

Publications (1)

Publication Number Publication Date
JPWO2022201644A1 true JPWO2022201644A1 (ja) 2022-09-29

Family

ID=83395269

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023508458A Pending JPWO2022201644A1 (ja) 2021-03-26 2021-12-03

Country Status (4)

Country Link
US (1) US20240189269A1 (ja)
EP (1) EP4316479A1 (ja)
JP (1) JPWO2022201644A1 (ja)
WO (1) WO2022201644A1 (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014013664A1 (ja) * 2012-07-19 2014-01-23 Ｓｂｉファーマ株式会社 インフルエンザウイルス感染症の予防・治療剤
US20210330622A1 (en) * 2020-04-22 2021-10-28 Nadimpally Satyavarahala Raju Viral infection treatment with 5-aminolevulinic acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014013664A1 (ja) * 2012-07-19 2014-01-23 Ｓｂｉファーマ株式会社 インフルエンザウイルス感染症の予防・治療剤
US20210330622A1 (en) * 2020-04-22 2021-10-28 Nadimpally Satyavarahala Raju Viral infection treatment with 5-aminolevulinic acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SAKURAI, YASUTERU ET AL.: "5-amino levulinic acid inhibits SARS-CoV-2 infection in vitro", BIOCHEM. BIOPHYS. RES. COMMUN., vol. 545, JPN6022003864, January 2021 (2021-01-01), pages 203 - 207, ISSN: 0005214940 *
TAKANO, TOMOMI ET AL.: "Possible Antiviral Activity of 5-Aminolevulinic Acid in Feline Infectious Peritonitis Virus (Feline", FRONT. VET. SCI., vol. 8, JPN6022003865, 10 February 2021 (2021-02-10), pages 647189, XP055867919, ISSN: 0005214941, DOI: 10.3389/fvets.2021.647189 *

Also Published As

Publication number Publication date
WO2022201644A1 (ja) 2022-09-29
EP4316479A1 (en) 2024-02-07
US20240189269A1 (en) 2024-06-13

Similar Documents

Publication Publication Date Title
BR112023012656A2 (ja)
BR102021015500A2 (ja)
JPWO2022014654A1 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
JPWO2022201644A1 (ja)
BR112023008976A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016200A2 (ja)
BR102021016176A2 (ja)
BR102021015566A2 (ja)
BR102021015450A8 (ja)
BR102021015220A2 (ja)
BR102021015247A2 (ja)
BR102021014044A2 (ja)
BR102021014056A2 (ja)
BR102021013929A2 (ja)
BR102021012571A2 (ja)
BR102021012230A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230922

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230922

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240403

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240520